Volume 19, Number 7—July 2013
Human Alveolar Echinococcosis in Kyrgyzstan
Human echinococcosis is a reportable disease in Kyrgyzstan. Between 1995 and 2011, human alveolar echinococcosis increased from <3 cases per year to >60 cases per year. The origins of this epidemic, which started in 2004, may be linked to the socioeconomic changes that followed the dissolution of the former Soviet Union.
Alveolar echinococcosis (AE) is a devastating disease in humans, caused by the larval stage of the fox tapeworm, Echinococcus multilocularis (1). In the absence of treatment, the condition is often fatal, although expensive and successful treatment options are available and have recently been documented to be effective (2). The closely related parasite E. granulosus, commonly transmitted between dogs and livestock, causes cystic echinococcosis (CE) when it infects humans. CE has emerged throughout central Asia following the dissolution of the former Soviet Union and has been attributed to changes in animal husbandry practices, decline in veterinary public health services, and increases in dog populations (3). We report evidence of an emerging epidemic of human AE in the former Soviet Republic of Kyrgyzstan.
Echinococcosis is notifiable in Kyrgyzstan, a small, mountainous, central Asian country (199,900 km2) of ≈5.5 million inhabitants. All confirmed diagnoses are reported to the Government Sanito-Epidemiology Unit in Bishkek. Cases are reported as either CE or AE by morphologic and histologic examination of resected lesions after surgical treatment. Age, sex, origin, and occupation of patients with reported cases are recorded. This reporting procedure has been used since the time of Soviet administration. However, the number of cases is likely underreported, and many case-patients with echinococcosis do not receive treatment because of widespread poverty and misdiagnoses. We analyzed the official reported cases of AE for the years 1995 through 2011 and present the annual numbers of all case-patients, categorized by sex and district of origin.
After the first AE case was recorded in 1996 in Kyrgyzstan, 0–3 cases occurred each year until 2003. Since 2004, the numbers of reported cases have increased substantially, reaching 61 in 2011 (Figure 1) (p<0.0001, χ2 for trend). The total number of AE cases reported from 1995 through 2011 was 291. Of these, 185 case-patients were female and 106 case-patients were male (p<0.0001, χ2). The mean age of case-patients was 33.4 years, with a range of 3–76 years. Eight cases occurred in children <10 years of age, and an additional 30 cases occurred in children 10–19 years of age (Table). The highest incidences were from the Osh, Issyk-Kul, and Naryn Oblasts (a subnational administrative division); the annual incidence in Naryn for the last 2 years of the study period was 7.1 cases per 100,000 population (Figure 2). All other districts had a mean annual incidence of <2 cases per 100,000, whereas the mean annual incidence nationwide is 1.2 cases per 100,000 with relatively few cases from the Batken and Talas Oblasts (Figure 2).
These data suggest an epidemic, at least as far as confirmed reported cases indicate, of AE in Kyrgyzstan that began in ≈2004. The case-patients reported here were also young (mean age 33 years) compared to case-patients in Europe, for example, in Switzerland, where the higher mean age is 54 years (2). Kyrgyzstan, however, has a young population; median age is 24.7 years, whereas the median age of those infected in Switzerland is 41.3 years (data from US Census Bureau, International Programs, www.census.gov/population/international/data/idb/informationGateway.php). This difference in the population pyramids means that Kyrgyzstan has a much higher proportion of children and young adults than Switzerland, and therefore a greater proportion of Kyrgyz case-patients would have been exposed and diagnosed at an earlier age.
Dogs are usually essential for CE transmission, and thus they are the key to the increasing human CE incidence reported previously (3). Dogs are highly susceptible to infection with E. multilocularis (4), and 18% of dogs from Naryn Oblast harbor this parasite, a similar prevalence to E. granulosus infection (5). Therefore, contact between humans and dogs responsible for transmission of CE could result in transmission of AE.
More than 90% of the estimated 18,000 annual new cases of AE throughout the world are in China, mainly the Tibetan plateau (6), where there is also a concomitant high prevalence of E. multilocularis infection in dogs (7). Dog contact has been reported as a risk factor for human AE on the Tibetan plateau (8). Therefore, E. multilocularis infection in dogs in Kyrgyzstan may be key in the development of the reported epidemic of human AE. The parasite has colonized dogs because dog populations have increased and because dogs scavenge for rodents. Dogs that spend a large proportion of time untied, and thus are able to roam, have a higher prevalence of E. multilocularis infection in Kyrgyzstan (5).
This epidemic also appeared 10–15 years after the dissolution of the Soviet Union. This time frame coincides with the hypothesized latent period of human AE. In Switzerland, human AE has also emerged, but this has been linked to an increase in the fox population (9). Unlike the situation in Switzerland, we have no data on fox populations and thus cannot speculate about any possible changes in fox and small animal ecology that could be an alternative hypothesis for changes in AE incidence. However, the recent incidence in Kyrgyzstan is 4–5 times higher than it is in Switzerland, and therefore the epidemiology of transmission to humans is likely to be different. However, among foxes in Kyrgyzstan, prevalence of infection with E. multilocularis is 65%, with a mean abundance of >8,500 parasites per fox (10), and this abundance of parasites may be critical in transmission to humans if substantial fox–human contact occurs. Nevertheless, E. multilocularis infection in foxes in Kyrgyzstan is unlikely to be a recent phenomenon because E. multilocularis was reported in rodent intermediate hosts in the 1950s (11).
Lithuania, another former Soviet republic, also reported increased numbers of AE cases during 1997–2006 (12). In Lithuania, involvement of dogs in the transmission of E. multilocularis has been suggested. There is also a report of human AE emergence in Poland (13), another former communist country, with a steady increase in cases from 1990 to 2011. In Poland, the fox population is increasing, and many AE cases originate in areas with large fox populations. The role of dogs in transmission in Poland cannot yet be clarified because of lack of data.
This report does not prove that human AE has increased in Kyrgystan. It is possible that reporting of cases may have improved. Nonetheless, AE has long been known in the states of the former Soviet Union; cases were diagnosed in Russia as early as 1900 (14). Thus it seems unlikely that a failure to diagnose large numbers of AE cases would have occurred, which would have to have been the situation if the incidence of human AE had remained constant. Furthermore, medical services were adversely affected during a period of severe economic hardship after the dissolution of the Soviet Union, thus making improved diagnosis an unlikely factor in the increased number of cases reported. In the disease-endemic area in central Europe, the numbers of reported cases of AE have increased since the disease was first described in the mid 19th century, and this increase may be due to improved diagnosis in recent decades (14). Increases in fox populations, particularly urban fox populations, may have provided the environment for increased transmission to humans (15), but to date, the only convincing evidence that this increase in fox populations has resulted in increased numbers of AE cases has come from Switzerland (9). In conclusion, AE appears to be a rapidly emerging problem in Kyrgyzstan, which may be related to profound socioeconomic changes that have occurred in the past 25 years.
Dr Usubalieva is a medical parasitologist at the Kyrgyz State Epidemiological Services in Bishkek, Kyrgyzstan. Her primary research interests include the epidemiology of parasitic zoonoses.
This work was supported by the Scientific Co-operation between Eastern Europe and Switzerland (SCOPES) program of the Swiss National Scientific Foundation.
- Eckert J, Deplazes P. Biological, epidemiological and clinical aspects of echinococcosis: a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107–35.
- Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008;49:72–7.
- Torgerson PR, Oguljahan B, Muminov AE, Karaeva RR, Kuttubaev OT, Aminjanov M, Present situation of cystic echinococcosis in Central Asia. Parasitol Int. 2006;55(Suppl):S207–12.
- Kapel CMO, Torgerson PR, Thompson RCA, Deplazes P. Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. Int J Parasitol. 2006;36:79–86.
- Ziadinov I, Mathis A, Trachsel D, Rysmukhambetova A, Abdyjaparov TA, Kuttubaev OT, Canine echinococcosis in Kyrgyzstan: using prevalence data adjusted for measurement error to develop transmission dynamics models. Int J Parasitol. 2008;38:1179–90.
- Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis. 2010;4:e722.
- Budke CM, Campos-Ponce M, Qian W, Torgerson PR. A canine purgation study and risk factor analysis for echinococcosis in a high endemic region of the Tibetan plateau. Vet Parasitol. 2005;127:43–9.
- Craig PS. Epidemiology of human alveolar echinococcosis in China. Parasitol Int. 2006;55(Supplement):S221–5.
- Schweiger A, Ammann RW, Candinas D, Clavien P-A, Eckert J, Gottstein B, Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis. 2007;13:878–82.
- Ziadinov I, Deplazes P, Mathis A, Mutunova B, Abdykerimov K, Nurgaziev R, Frequency distribution of Echinococcus multilocularis and other helminths of foxes in Kyrgyzstan. Vet Parasitol. 2010;171:286–92.
- Gagarin VG, Steshenko VM, Tokobaev MM. Role of rodents in the distribution of helminth zoonoses. Works Inst. Zool. Parasitol. Kyrgyz Acad. Sci. 1957;6:159–61.
- Bruzinskaite R, Marcinkute A, Strupas K, Sokolovas V, Deplazes P, Mathis A, Alveolar echinococcosis, Lithuania. Emerg Infect Dis. 2007;13:1618–9.
- Hahorski WL, Knap JP, Pawlowski ZS, Krawczyk M, Polanski J, Stefaniak J, Human alveolar echinococcosis in Poland: 1990–2011. PLoS Negl Trop Dis. 2013;7: e1986. PMID:23301116
- Vuitton DA, Qian W, Hong-Xia Z, Raoul F, Knapp J, Bresson-Hadni S, A historical view of alveolar echinococcosis, 160 years after the discovery of the first case in humans: part 1. What have we learnt on the distribution of the disease and on its parasitic agent? Chin Med J (Engl). 2011;124:2943–53 .
- Romig T. Echinococcus multilocularis in Europe—state of the art. Vet Res Commun. 2009;33:S31–4.
- Figure 1. . Number of alveoloar echinococcosis cases reported in Kyrgyzstan, by patient sex, 1995–2011.
- Figure 2. . Relative incidence of alveoloar echinococcosis in Kyrgyzstan, by district, 1995–2011. The size of the bars on the map is proportional to the incidence.
Suggested citation for this article: Usubalieva J. Minbaeva G, Ziadinov I, Peplazes P, Torgerson PR. Human alveolar echinococcosis in Kyrgyzstan. Emerg Infect Dis [Internet]. 2013 Jul [date cited]. http://dx.doi.org/10.3201/eid1907.121405
Please use the form below to submit correspondence to the authors or contact them at the following address:
Paul Torgerson, Vetsuisse Faculty, Section of Veterinary Epidemiology Winterthurestrasse 270, Zurich CH-8057, Switzerland
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 17, 2013
- Page last updated: June 17, 2013
- Page last reviewed: June 17, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)